INS and Hypertension: Visceral fat became the subject of interest in the 1980s when Ruderman et al. [13] described a case of patients with symptoms indicative of the metabolic syndromes—reduced insulin sensitivity, hypertension, T2DM, and hypertriglyceridemia—despite normal body mass index (BMI).